About R.L.Fine Chem Private Limited
Data last updated:
R.L.Fine Chem Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of Anam Fine Chemicals Private Limited. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 02 August 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24100KA2011PTC059846. Its GSTIN is 29AAFCR4326L1Z0 (Karnataka). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹5.13 Lakh. It is led by directors including Rajesh Umakant Naik (Whole-Time Director) and Anil Jain.
Its last annual general meeting (AGM) was held on 27 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at #C – 10 1st Cross Kssidc Industrial Area Yelahanka, Bangalore, Karnataka, India – 560064.
As per the financials filed for FY 2025, the company reported a revenue of ₹360.48 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹51.94 Cr (net margin 14.4%) and EBITDA of ₹79.83 Cr (EBITDA margin 22.1%). Revenue has grown at a compounded annual rate (CAGR) of 4% over five years.
The company has about 714 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: R L Fine Chem. As per MCA filings, the company has open charges of ₹478.91 Cr and satisfied charges of ₹549.74 Cr on record. Court records list 17 cases involving the company, including 4 filed by the company and 14 filed against it; 3 cases are pending. The company has 5 deals on record (3 secondary share transfers, 2 funding rounds), with disclosed funding of ₹54.73 Cr; the latest was in March 2024. Its 9 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 4 smaller; the largest is Alchem International Private Limited with revenue of ₹371.17 Cr. The company has 10 MSME Form 1 returns on record between 2020 and 2024, listing 1,492 overdue payments to 100 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rlfinechem.com.
Company details
Contact details
R.L.Fine Chem Private Limited's registered office is in Bangalore, Karnataka. Its website is rlfinechem.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address#C – 10 1st Cross Kssidc Industrial Area Yelahanka, Bangalore, Karnataka, India – 560064
- IndustryPharma, API Manufacturers
To see the full contact details of R.L.Fine Chem Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
R.L.Fine Chem operates one associated brand: R L Fine Chem. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical company engaged in manufacturing of Active Pharmaceutical Ingredients (APIs) | rlfinechem.com |
Business activity
The main business activity of R.L.Fine Chem is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of R.L.Fine Chem Private Limited, buy the company report.
Financials of R.L.Fine Chem Private Limited
FY 2024 filings availableR.L.Fine Chem Private Limited reported revenue of ₹360.48 Cr (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 6% growth in the latest year. EBITDA rose 352% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹79.83 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹51.94 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 22.1% | ||||
| Net Profit Margin | 14.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of R.L.Fine Chem Private Limited, buy the company report.
Board of directors and KMP of R.L.Fine Chem Private Limited
R.L.Fine Chem Private Limited currently reports 3 directors and 1 key managerial person. 18 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Umakant Naik | Whole-Time Director | 28 Jan 2025 | 1 Years 9 Months | Current |
| Sharat Pandu Rang Narasapur | Ceo | 17 Jun 2024 | 2 Years 4 Months | Current |
| Anil Jain | Director | 01 Apr 2024 | 2 Years 6 Months | Current |
| Brian William Tempest Also directs: Religare Capital Markets Limited | Director | 09 May 2024 | 2 Years 5 Months | Current |
Peer comparison
R.L.Fine Chem Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alchem International Private Limited | ₹371.17 Cr (FY 2025) | 7.0% | New Delhi, Delhi, India | |||
| M. J. Biopharm Private Limited | ₹367.26 Cr (FY 2025) | 24.0% | Pune, Maharashtra, India | |||
| Oneiro Lifecare Private Limited | ₹366.81 Cr (FY 2025) | 14.0% | Vadodara, Gujarat, India | |||
| Kopran Research Laboratories Limited | ₹365.89 Cr (FY 2025) | 13.0% | Mumbai, Maharashtra, India | |||
| Zydus Takeda Healthcare Private Limited | ₹361.57 Cr (FY 2025) | -54.0% | Navi Mumbai, Maharashtra, India | |||
| R.L.Fine Chem Private Limitedthis company | ₹360.48 Cr (FY 2025) | ₹51.94 Cr | 14.4% | 6.0% | 714 | Bangalore, Karnataka, India |
| Vital Laboratories Private Limited | ₹357.13 Cr (FY 2025) | 7.0% | Mumbai, Maharashtra, India | |||
| Haleos Labs Limited | ₹349.58 Cr (FY 2025) | 13.0% | Hyderabad, Telangana, India | |||
| SCL Lifesciences Limited | ₹340.47 Cr (FY 2025) | -4.0% | Punjab, India | |||
| Valiant Laboratories Limited | ₹338.77 Cr (FY 2023) | 61.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of R.L.Fine Chem Private Limited, buy the company report.
Auditor
R.L.Fine Chem Private Limited is audited by K.S. Rao & Co for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K.S. Rao & Co | FY 2024 | 003109S |
Shareholding
The shareholding of R.L.Fine Chem Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of R.L.Fine Chem Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Sep 2025 | 101165240 | Others | ₹60 Cr | Open | |
| 30 Sep 2024 | 100993254 | Hdfc Bank Limited | ₹10.2 Cr | Open | |
| 10 Jun 2024 | 100941501 | Hdfc Bank Limited | ₹50.55 Lakh | Open | |
| 06 Mar 2024 | 100882034 | Hdfc Bank Limited | ₹18 Cr | Open | |
| 06 Jul 2023 | 100754128 | Idbi Trusteeship Services Limited | ₹209.2 Cr | Open |
To see the full charge records of R.L.Fine Chem Private Limited, buy the company report.
Total charge records: 20 View all charges
Deals & funding
R.L.Fine Chem Private Limited has 5 deals on record (3 secondary share transfers, 2 funding rounds), with disclosed funding of ₹54.73 Cr; the latest was in March 2024.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Secondary share transfer | Undisclosed | Seller: MAPE Group |
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: Verve Industries Private Limited Seller: Chandrapore Estates Private Limited |
| Aug 2021 | Secondary share transfer | Undisclosed | Buyer: Refex Life Sciences Private Limited Seller: 4 individuals |
| Aug 2016 | Funding round | ₹54.71 Cr | Investors: Chandrapore Estates Private Limited , MAPE Group |
| Jan 2014 | Funding round | ₹2.2 Lakh | Investors: 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
R.L.Fine Chem Private Limited has 17 court cases on record: 4 filed by R.L.Fine Chem, 14 filed against it. 3 cases are pending and 14 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 7 | 4 | 2 |
| District courts | 6 | 6 | 1 |
| NCLT | 3 | 3 | 0 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 17)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Karnataka | Appeal | Filed by the company against Tejkamal Pharmaceuticals Pvt Ltd | Pending |
| High Court, MAHARASHTRA | Commercial suit | Filed against the company by Mape Pharmascience LLP and Anr and 1 other | Disposed |
| NCLT, Bengaluru | Insolvency matter | Filed against the company by Ray Life Sciences Private Limited | Disposed |
| District court, BENGALURU, Karnataka | Civil suit | Filed against the company by RL Fine Chem | Disposed |
| District court, BENGALURU, Karnataka | Civil suit | Filed by the company against RL Fine Chem Private Limited | Disposed |
To see the full case history of R.L.Fine Chem Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
R.L.Fine Chem Private Limited has 10 MSME Form 1 returns on record between 2020 and 2024, listing 1,492 overdue payments to 100 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 100)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| United Acid & Chemical Co. | |||
| Als Testing Services India Private Limited | |||
| an individual supplier | |||
| Subham Safety Enterprises | |||
| an individual supplier |
To see the full MSME payment records of R.L.Fine Chem Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
R.L.Fine Chem has 1 associated company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
Employees & EPFO
R.L.Fine Chem Private Limited has a workforce of 714 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
GST
R.L.Fine Chem has 3 GST registrations: 3 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAFCR4326L1Z0 | Karnataka | Active | 01 Jul 2017 |
| 29AAFCR4326L2ZZ | Karnataka | Active | 23 Jun 2025 |
| 37AAFCR4326L1Z3 | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of R.L.Fine Chem Private Limited, buy the company report.
Recent activity
R.L.Fine Chem Private Limited has 21 board changes on record since 2013: 4 appointments and 17 cessations. The latest: Rajesh Umakant Naik was appointed as Whole-Time Director on 28 Jan 2025.
55 earlier events are in the company report.
Frequently asked questions
R.L.Fine Chem is an active private limited company based in Bangalore, Karnataka, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 02 August 2011 (15+ years old) and is registered under CIN U24100KA2011PTC059846.
R.L.Fine Chem has 4 current directors and KMP:
- Rajesh Umakant Naik - Whole-Time Director
- Anil Jain - Director
- Brian William Tempest - Director
- Sharat Pandu Rang Narasapur - Ceo
The latest financial statements of R.L.Fine Chem on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 27 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of R.L.Fine Chem is 29AAFCR4326L1Z0, registered in Karnataka. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 29AAFCR4326L2ZZ (Karnataka), 37AAFCR4326L1Z3 (Andhra Pradesh).
The CIN (Corporate Identification Number) of R.L.Fine Chem is U24100KA2011PTC059846. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
R.L.Fine Chem has 17 court cases on record: 4 filed by the company and 14 filed against it. 3 are pending. Most are in the high courts.
R.L.Fine Chem was incorporated on 02 August 2011, making it 15+ years old. It is registered with the Registrar of Companies, Bangalore.
R.L.Fine Chem has 5 deals on record (3 secondary share transfers, 2 funding rounds), with disclosed funding of ₹54.73 Cr; the latest was in March 2024.
The peers of R.L.Fine Chem by revenue are Alchem International Private Limited, M. J. Biopharm Private Limited, Oneiro Lifecare Private Limited, Kopran Research Laboratories Limited, Zydus Takeda Healthcare Private Limited and 4 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rajesh Umakant Naik was appointed as Whole-Time Director on 28 Jan 2025. Rajesh Umakant Naik ceased to be Additional Director on 28 Jan 2025. Mallesha Kagepura Mariyappa ceased to be Director on 14 Oct 2024. R.L.Fine Chem has 21 board changes on record in total.
R.L.Fine Chem has 10 MSME Form 1 returns on record between 2020 and 2024, listing 1,492 overdue payments to 100 micro and small suppliers. The latest return was filed on 25 Apr 2024.
R.L.Fine Chem can be reached through the website rlfinechem.com. Its registered office is in Bangalore, Karnataka, India.